Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 9
Submit an article Journal homepage
190
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

CD22 expression in acute myeloid leukemia: close correlation with interleukin-2 receptor α-chain (CD25) expression and poor prognosis

Kazunori Nakasea Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan;b Department of Hematology and Oncology, Mie University Hospital, Tsu, JapanCorrespondence[email protected]
View further author information
,
Isao Tanakac Department of Internal Medicine, Suzuka Kaisei Hospital, Suzuka, JapanView further author information
,
Isao Tawarab Department of Hematology and Oncology, Mie University Hospital, Tsu, JapanView further author information
&
Hiroshi Shikua Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, JapanView further author information
Pages 2251-2253 | Received 08 Dec 2021, Accepted 29 Mar 2022, Published online: 20 Apr 2022

References

  • Nair R, Salinas-Illarena A, Baldauf HM. New strategies to treat AML: novel insights into AML survival pathways and combination therapies. Leukemia. 2021;35(2):299–311.
  • Cross AH, Goorha RM, Nuss R, et al. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood. 1988;72(2):579–587.
  • Miwa H, Mizutani M, Mahmud N, et al. Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell origin. Leukemia. 1998;12(1):44–51.
  • Kita K, Miwa H, Nakase K, et al. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood. 1993;81(9):2399–2405.
  • Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22; q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood. 1992; 80(2):470–477.
  • Gonen M, Sun Z, Figueroa ME, et al. CD25 expression status improves prognostic risk stratification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. Blood. 2012;120(11):2297–2306.
  • Nguyen CH, Schlerka A, Grandits AM, et al. IL2RA promotes aggressiveness and stem cell-related properties of acute myeloid leukemia. Cancer Res. 2020;80(20):4527–4539.
  • Drexler HG, Thiel E, Ludwig WD. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia. 1993;7(4):489–498.
  • Sato N, Kishi K, Toba K, et al. Simultaneous expression of CD13, CD22 and CD25 is related to the expression of Fc epsilon R1 in non-lymphoid leukemia. Leuk Res. 2004;28(7):691–698.
  • Saito Y, Kitamura H, Hijikata A, et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med. 2010;2(17):ra9.
  • Jordan CT, Upchurch D, Szilvassy SJ, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 2000;14(10):1777–1784.
  • Stock W, Martinelli G, Stelljes M, et al. Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemia. Cancer. 2021;127(6):905–913.
  • Toba K, Hanawa H, Fuse I, et al. Difference in CD22 molecules in human B cells and basophils. Exp Hematol. 2002;30(3):205–211.
  • Acon-Laws M, Bayerl MG, Ehman C, et al. Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti-CD22 therapies. AKA not all anti-CD22 antibodies are created equal. Am J Hematol. 2011;86(10):891–892.
  • Bohme M, Kayser S. Immune-based therapeutic strategies for acute myeloid leukemia. Cancers. 2021;14(1):105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.